Indaptus Therapeutics Inc. Company Profile
NASDAQ: INDPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Indaptus Therapeutics at a glance
Indaptus Therapeutics Inc. (NASDAQ: INDP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New York, NY. Indaptus Therapeutics is led by Mr. Junyi Dai and employs about 5 people. At a market capitalization of $433.2 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001857044, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Indaptus Therapeutics do?
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Indaptus Therapeutics Inc.
- Ticker
- NASDAQ: INDP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Junyi Dai
- Employees
- 5
- Headquarters
- Three Columbus Circle, New York, NY, United States
- Phone
- 646 427 2727
- Website
- indaptusrx.com
- Market cap
- $433.16M
- SEC CIK
- 0001857044
- Latest annual report
- 10-K · Mar 17, 2026
Companies similar to Indaptus Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EOLSEvolus Inc. | 6.52 | -6.86% | $431.55M | vs INDP |
| AQSTAquestive Therapeutics Inc. | 3.46 | -6.61% | $434.88M | vs INDP |
| CAPRCapricor Therapeutics Inc. | 7.59 | +0.80% | $441.30M | vs INDP |
| LYELLyell Immunopharma Inc. | 13.80 | +1.62% | $441.82M | vs INDP |
| CTMXCytomX Therapeutics Inc. | 2.03 | -0.98% | $442.55M | vs INDP |
| ARVNArvinas Inc. | 6.46 | -4.15% | $423.03M | vs INDP |
| PRTAProthena Corporation plc | 8.22 | -2.14% | $422.10M | vs INDP |
| AMRNAmarin Corporation plc | 10.57 | -6.13% | $444.39M | vs INDP |